“A key to offering patients precision-medicine treatment”
Another global life-science company, Amgen, has now established itself in Hagastaden. In this interview, Karin Järperud shares how the company is working to strengthen clinical research, increase patient value, and accelerate innovation. She also reflects on Amgen’s collaboration with Fryshuset through a mentoring program – and how it has contributed to positive development within the company itself
Karin Järperud, Country Sr Director, and Ola Gelin, Communications and digital lead Sweden.
The global biotechnology company Amgen works to improve the lives of people living with serious illnesses. They have been active in Sweden since 1995 and are particularly involved in therapeutic areas such as oncology, hematology, inflammation, cardiometabolic diseases, and rare diseases.
– With a strong patient focus and a culture built on science, ethics, and collaboration, we strive to be a reliable partner for both healthcare and society at large, says Karin Järperud, Country Sr Director.
Our newsletter focuses primarily on life science and highlights key players, topics and development within the innovation ecosystem in the Stockholm-Uppsala region.
